NORTH AMERICA MALE INFERTILITY MARKET 2023-2030

As per Triton’s research report, the North America male infertility market is estimated to progress with a CAGR of 4.41% in revenue during the forecasting phase 2023-2030.

Report scope can be customized per your requirements - Request Free Sample Report

The countries reviewed in the region are:

• United States

• Canada

In North America, the growth of the male infertility market is primarily fueled by initiatives by major market players, alongside the development of advanced devices resulting from substantial R&D spending. Furthermore, ongoing approvals and launches of advanced diagnostic devices and surged awareness about male infertility further bolster the adoption of assisted reproductive technologies for infertility treatment. Hence, these factors open new avenues for the male infertility market across the region.

The United States secures the majority of the share in the studied market. The nation’s growth can be attributed to increasing infertility rates, growing adoption of assisted reproductive technologies, and the presence of prominent market players. The country’s most prevalent types of male infertility are idiopathic infertility and infertility caused by varicocele. According to industry sources, approximately 1 in 8 couples in America experience fertility issues. This significantly elevates the demand for infertility treatments, such as assisted reproductive technology and hormone treatment. Hence, as stated above, these factors are expected to generate significant opportunities for the male infertility market.

Computer-assisted semen analysis (CASA) employs an electronic imaging system and advanced software to visualize and assess specific sperm properties accurately. These systems offer distinct advantages compared to conventional analysis, providing precise and reproducible results. As per estimates, computer-assisted semen analysis is expected to witness substantial growth due to technological advancements. CASA systems have evolved significantly in recent years, benefiting from improved image-capturing devices for microscopes, increased computational power in smaller computers, utilization of new programming languages, and the development of updated and expanded software algorithms.

The market’s growth is determined based on test type and treatment. The treatment section is branched into computer-assisted semen analysis, DNA fragmentation technique, oxidative stress analysis, sperm agglutination, sperm penetration assay, microscopic examination, and other test types.

The well-known companies in the market comprise Aytu Biopharma, Sanofi SA, Zydus Lifesciences Limited, CinnaGen Co, and Laboratory Corporation of America Holdings.

Laboratory Corporation of America Holdings is a US-based life sciences company that offers clinical laboratory and full-cycle drug development services. Established in 1995 through the merger of NHL and RBL, the company operates through two segments: drug development and diagnostics. It conducts various tests utilizing blood, tissue, and other specimens. These tests are used by hospitals, doctors, other healthcare professionals, and commercial clients to diagnose, monitor, and treat various diseases.

Key deliverables of the report:

· Market CAGR during the forecasting years 2023-2030

· Detailed data highlighting key insights, industry components, and market strategies

· Comprehensive information and estimation of the male infertility market revenue growth in North America and its influence on the parent market

· In-depth study of forthcoming trends in consumer behavioral patterns

· A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

· A wide-ranging study of factors that will challenge the NA male infertility market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.

Major Players in the Market

Related Reports

Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT

Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2022-2028

Market by Therapeutics, Diagno ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA MALE INFERTILITY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. PARENT MARKET ANALYSIS

2.2. IMPACT ANALYSIS ON THE MALE INFERTILITY MARKET

2.2.1. COVID-19 IMPACT

2.2.2. UKRAINE-RUSSIA WAR IMPACT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET MATURITY ANALYSIS

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. MERGERS & ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. PREVALENCE OF INFERTILITY

2.6.2. USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES

2.6.3. TECHNOLOGICAL INNOVATIONS AND ADVANCEMENTS

2.7. MARKET CHALLENGE

2.7.1. HIGH COST OF TREATMENT

2.8. MARKET OPPORTUNITIES

2.8.1. INCREASING ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES

2.8.2. GROWING AVAILABILITY OF INFERTILITY TREATMENT DRUGS, PROCEDURES, AND DEVICES

2.8.3. GOVERNMENT INITIATIVES TOWARD IMPROVING REIMBURSEMENT POLICIES

2.9. ANALYST PERSPECTIVE

3. NORTH AMERICA MALE INFERTILITY MARKET – BY TEST TYPE

3.1. DNA FRAGMENTATION TECHNIQUE

3.2. OXIDATIVE STRESS ANALYSIS

3.3. MICROSCOPIC EXAMINATION

3.4. SPERM AGGLUTINATION

3.5. COMPUTER-ASSISTED SEMEN ANALYSIS

3.6. SPERM PENETRATION ASSAY

3.7. OTHER TEST TYPES

4. NORTH AMERICA MALE INFERTILITY MARKET – BY TREATMENT

4.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY

4.2. MEDICATIONS

5. NORTH AMERICA MALE INFERTILITY MARKET – BY COUNTRY OUTLOOK

5.1. COUNTRY ANALYSIS

5.1.1. UNITED STATES

5.1.1.1. UNITED STATES MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.2. CANADA

5.1.2.1. CANADA MALE INFERTILITY MARKET FORECAST & PROSPECTS

6. COMPETITIVE LANDSCAPE

6.1. HALOTECH DNA

6.1.1. OVERVIEW

6.1.2. PRODUCT PORTFOLIO

6.2. EMD SERONO INC

6.2.1. OVERVIEW

6.2.2. PRODUCT PORTFOLIO

6.2.3. KEY STRENGTHS

6.2.4. KEY CHALLENGES

6.3. ENDO INTERNATIONAL PLC

6.3.1. OVERVIEW

6.3.2. PRODUCT PORTFOLIO

6.3.3. KEY STRENGTHS

6.3.4. KEY CHALLENGES

6.4. VITROLIFE

6.4.1. OVERVIEW

6.4.2. PRODUCT PORTFOLIO

6.4.3. KEY STRENGTHS

6.4.4. KEY CHALLENGES

6.5. BAYER AG

6.5.1. OVERVIEW

6.5.2. PRODUCT PORTFOLIO

6.5.3. KEY STRENGTHS

6.5.4. KEY CHALLENGES

6.6. AYTU BIOPHARMA

6.6.1. OVERVIEW

6.6.2. PRODUCT PORTFOLIO

6.6.3. KEY STRENGTHS

6.6.4. KEY CHALLENGES

6.7. ZYDUS LIFESCIENCES LIMITED

6.7.1. OVERVIEW

6.7.2. PRODUCT PORTFOLIO

6.7.3. KEY STRENGTHS

6.7.4. KEY CHALLENGES

6.8. CINNAGEN CO

6.8.1. OVERVIEW

6.8.2. PRODUCT PORTFOLIO

6.8.3. KEY STRENGTHS

6.8.4. KEY CHALLENGES

6.9. SANOFI SA

6.9.1. OVERVIEW

6.9.2. PRODUCT PORTFOLIO

6.9.3. KEY STRENGTHS

6.9.4. KEY CHALLENGES

6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

6.10.1. OVERVIEW

6.10.2. PRODUCT PORTFOLIO

6.10.3. KEY STRENGTHS

6.10.4. KEY CHALLENGES

7. RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: LIST OF PRODUCT LAUNCHES

TABLE 4: LIST OF MERGERS & ACQUISITIONS

TABLE 5: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 6: NORTH AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)

TABLE 7: NORTH AMERICA MALE INFERTILITY MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)

TABLE 8: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS

FIGURE 2: NORTH AMERICA MALE INFERTILITY MARKET, BY TYPE, 2022 & 2030 (IN %)

FIGURE 3: NORTH AMERICA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)

FIGURE 4: NORTH AMERICA MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 5: NORTH AMERICA MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2030 (IN $ MILLION)

FIGURE 6: NORTH AMERICA MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2030 (IN $ MILLION)

FIGURE 7: NORTH AMERICA MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 8: NORTH AMERICA MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2030 (IN $ MILLION)

FIGURE 9: NORTH AMERICA MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2030 (IN $ MILLION)

FIGURE 10: NORTH AMERICA MALE INFERTILITY MARKET, BY TREATMENT, 2022 & 2030 (IN %)

FIGURE 11: NORTH AMERICA MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)

FIGURE 12: NORTH AMERICA MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 13: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: UNITED STATES MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: CANADA MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)